TherMatrx TMx-2000 PMA Backed By Impressive Pivotal Trial Results
This article was originally published in The Gray Sheet
Executive Summary
TherMatrx' modular premarket approval application for the TMx-2000 microwave thermotherapy to treat benign prostatic hyperplasia is on track for approval by late 2000 or early 2001, following submission of the first module in April.